The news of JP Morgan maintaining an Underweight rating on DocuSign and raising the price target from $48 to $50 may not have a significant short-term impact on the stock price. The price target increase is relatively small, and the Underweight rating remains unchanged, suggesting that the analyst still sees potential downside risks for the stock.